Pediatric Clinical Pharmacology [recurso electrónico] / edited by Hannsjörg W. Seyberth, Anders Rane, Matthias Schwab.
Tipo de material:
TextoSeries Handbook of Experimental Pharmacology ; 205Editor: Berlin, Heidelberg : Springer Berlin Heidelberg, 2011Edición: FirstDescripción: XII, 384 p. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783642201950Tema(s): Medicine | Medical laboratories | Toxicology | Pediatrics | Biomedicine | Pharmacology/Toxicology | Pediatrics | Laboratory MedicineFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 615 Clasificación LoC:RM1-950Recursos en línea: Libro electrónico
Contenidos:
En: Springer eBooksResumen: The objective of this volume is to give an overview of the present state of the art of pediatric clinical pharmacology including developmental physiology, pediatric-specific pathology, special tools and methods for development of drugs for children (assessment of efficacy, toxicity, long-term safety etc.) as well as regulatory and ethical knowledge and skills. In the future, structural and educational changes have to lead back to a closer cooperation and interaction of pediatrics with (clinical) pharmacology and pharmacy.
Preface -- Part 1: General Considerations and methodological aspects -- Part 2: Development of pediatric medicines -- Part 3: Specific pediatric pharmacology.
| Tipo de ítem | Biblioteca actual | Colección | Signatura | Copia número | Estado | Fecha de vencimiento | Código de barras |
|---|---|---|---|---|---|---|---|
| Libro Electrónico | Biblioteca Electrónica | Colección de Libros Electrónicos | RM1 -950 (Browse shelf(Abre debajo)) | 1 | No para préstamo | 376029-2001 |
Preface -- Part 1: General Considerations and methodological aspects -- Part 2: Development of pediatric medicines -- Part 3: Specific pediatric pharmacology.
The objective of this volume is to give an overview of the present state of the art of pediatric clinical pharmacology including developmental physiology, pediatric-specific pathology, special tools and methods for development of drugs for children (assessment of efficacy, toxicity, long-term safety etc.) as well as regulatory and ethical knowledge and skills. In the future, structural and educational changes have to lead back to a closer cooperation and interaction of pediatrics with (clinical) pharmacology and pharmacy.
19
